Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1573921

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1573921

Treatment Planning Systems and Advanced Image Processing Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

PUBLISHED:
PAGES: 280 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global Treatment Planning Systems and Advanced Image Processing Market was valued at approximately USD 2 billion in 2023 and is projected to indicate a growth rate of 8.6% CAGR from 2024 to 2032. Treatment planning systems craft precise treatment plans for radiation therapy patients, while advanced image processing enhances, analyzes, and interprets medical images using sophisticated algorithms. The rising incidence of cancer and an increase in medical imaging procedures are driving demand for treatment planning systems, boosting market growth. The global market's expansion is also driven by the need for precise oncology treatments using advanced image processing technology.

The overall treatment planning systems and advanced image processing industry are classified based on the component, application, technology, end-user, and region.

Segmenting the market by component, treatment planning systems led to a revenue of USD 1.3 billion in 2023. This segment's dominance is due to the escalating cancer prevalence and the growing demand for precise oncology therapy solutions. Awareness of the benefits of treatment planning software, especially in radiotherapy, further fuels this segment's growth. Advancements in healthcare infrastructure, public-private partnerships, and a shift towards software solutions over traditional methods also drive market expansion. For instance, in February 2021, Fujitsu Limited collaborated with the University of Toronto to optimize radiation treatment plans for brain tumors and arteriovenous malformations.

By application, the oncology segment led in 2023 with a revenue of USD 994.8 million and is projected to grow at a CAGR of 8.8%. The global surge in cancer cases drives demand for advanced oncology treatment planning systems. Innovations in imaging technologies, particularly AI-driven image processing and machine learning algorithms, enhance treatment planning accuracy and efficiency, propelling market growth. The rising preference for radiotherapy for various cancers has increased demand for advanced treatment planning software, optimizing radiation dosage and minimizing side effects.

The North American market for treatment planning systems and advanced image processing is forecasted to reach USD 1.9 billion by 2032, driven by the region's robust healthcare infrastructure. In 2023, the U.S. led the North American market with a revenue of USD 822.2 million. The U.S. market's momentum is fueled by a rising cancer incidence across diverse age groups and an increasing demand for advanced treatment planning tools and imaging technologies. Data from the National Cancer Institute in January 2022 highlighted about 18.1 million cancer survivors in the U.S., underscoring the pressing demand for innovative healthcare solutions in cancer management.

Product Code: 11148

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising prevalence of cancer
      • 3.2.1.2 Continuous innovations in imaging and treatment technologies
      • 3.2.1.3 Shift towards personalized treatment
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Significant costs associated with acquiring and maintaining advanced treatment planning systems
      • 3.2.2.2 Stringent regulatory requirements and lengthy approval processes
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Regulatory landscape
  • 3.6 Technological landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Advanced image processing systems
  • 5.3 Treatment planning systems

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Oncology
  • 6.3 Cardiology
  • 6.4 Neurology
  • 6.5 Orthopedics
  • 6.6 Other applications

Chapter 7 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 MRI-based planning
  • 7.3 CT-based planning
  • 7.4 Radiation therapy
    • 7.4.1 3D conformal radiation therapy
    • 7.4.2 Intensity-modulated radiation therapy
    • 7.4.3 Image-guided radiation therapy
    • 7.4.4 Stereotactic body radiation therapy
  • 7.5 Proton beam therapy

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Ambulatory surgical centers
  • 8.4 Specialty clinics
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Accuray Incorporated
  • 10.2 Agfa-Gevaert Group
  • 10.3 Brainlab AG
  • 10.4 Canon Medical Systems Corporation
  • 10.5 C-RAD AB
  • 10.6 Elekta AB
  • 10.7 GE HealthCare Technologies Inc.
  • 10.8 Hitachi, Ltd.
  • 10.9 IBA Radiopharma Solutions
  • 10.10 IntraOp Medical Corporation
  • 10.11 Koninklijke Philips N.V.
  • 10.12 Mercurius Health
  • 10.13 Mirada Medical Limited
  • 10.14 Siemens Healthineers AG
  • 10.15 ViewRay, Inc.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!